Bellevue Group »

Axsome Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $51M 635k 79.59
2023-09-30 $44M 632k 69.89
2023-06-30 $41M 574k 71.86
2023-03-31 $27M 441k 61.68
2022-12-31 $34M 437k 77.13
2022-09-30 $22M 497k 44.62
2022-06-30 $31M 817k 38.30
2022-03-31 $30M 720k 41.39
2021-12-31 $25M 652k 37.78
2021-09-30 $25M 753k 32.96
2021-06-30 $24M 352k 67.46